Max Druchok - SoftServe Subject Matter Expert

Don't want to miss a thing?Subscribe to get expert insights, in-depth research, and the latest updates from our team.

ML Achieves Promising Results in Drug Discovery, Even With Limited Data

Explore machine learning's role in drug discovery in SoftServe’s study.

SoftServe empowers companies to go beyond existing barriers to discover solutions—saving time and money.

Learn more about our end-to-end molecular docking pipeline that combines deep learning and DFT approaches to predict protein-peptide docking.